What You Should Know:
- Phenomix Sciences, a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment, announced it has been awarded the first patent related to its obesity phenotyping technology.
- The patent (No. 11,740,247, titled “Methods and Materials for Assessing and Treating Obesity”) covers methods for treating obesity by identifying phenotypes through obesity analyte signatures and administering interventions, such
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Komodo Health Launches MapLab For Enterprise Healthcare Insights
What You Should Know:
Komodo Health today introduced MapLab™, the first all-in-one offering for healthcare and Life Sciences companies to generate insights into disease trends, treatment pathways, patient populations, and a host of other complex research questions.The technology ushers in a new, fully integrated insights workflow solution for the industry to more easily and rapidly unearth rich insights that will help reduce disease burden at scale. MapLab includes robust data science
Read More
Atropos Health Partners, Janssen Partner to Accelerate Clinical Trials with RWD
What You Should Know:
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced an agreement with Janssen Research & Development, LLC (Janssen), a Johnson & Johnson company, to help accelerate clinical development with real-world data analysis.Building upon an existing collaboration, under the new agreement, Atropos and Janssen data scientists will utilize Atropos’s software platform to interrogate
Read More
Mission Bio Announces and Launches Single-Cell Measurable Residual Disease (MRD) Assay
What You Should Know:
Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, announced the commercial launch of the Tapestri® Single-cell MRD (scMRD) AML Multiomics Assay.The company designed the scMRD AML Multiomics Assay to bring unprecedented resolution to disease relapse and recurrence in acute myeloid leukemia (AML), demonstrating the potential of single-cell DNA and protein multiomics to identify therapeutic targets in recurrent AML.
Unearthing
Read More
How Digital Health Tools Can Help Promote Vaccine Adherence
A so-called “tripledemic” — the convergence of flu, RSV and COVID-19 — led to significant morbidity and mortality, and it also forced the cancellation or delay of numerous medical procedures at overwhelmed health systems. This year, there’s an RSV vaccine joining flu and COVID-19 vaccines, and it could help Americans avoid repeating history — but only if patients get recommended vaccines.
The events over the last several years have impacted the way many people view vaccines, sometimes
Read More
The Key to a Competitive Edge in Life Sciences: The Network
The life sciences industry sits at the cross-section of virtually all the technological advancements driving today’s economy. Not only is it steeped in cutting-edge chem-bio research and development, it relies heavily on advanced computing infrastructure to support massive data analytics and modeling.
At the same time, it remains a heavily regulated industry that must cope with substantial and constantly changing rules and regulations imposed by dozens of jurisdictions around the world. To
Read More
Belong.Life Launches AI Clinical Trial Matching Assistant for Cancer
What You Should Know:
- Belong.Life today announced the launch of Tara, a new conversational AI SaaS solution to assist health providers and CROs with cancer clinical trial matching and recruitment.
- Available as a SaaS solution for providers, hospitals, health systems, CROs and other organizations, the technology can be embedded into websites, mobile apps or text messaging platforms to enable easy communication with opt-in patients.
AI SaaS Solution for Cancer Clinical Trial
Read More
myTomorrows, Congenica Partner to Advance Precision Oncology by Accelerating Clinical Trial Recruitment
What You Should Know:
- Congenica, a digital health company specializing in the provision of software and solutions for genomic data analysis and interpretation, and myTomorrows, a global platform facilitating access to pre-approval treatments and clinical trials, have partnered to expedite access to precision oncology for cancer patients worldwide.
- The strategic partnership between Congenica and myTomorrows will open new opportunities for physicians to search for access to
Read More
79% of Healthcare Execs Believe Most Drug Diversion Goes Undetected
What You Should Know:
Substance use disorder has far-reaching impacts across society, and healthcare workers are not immune. In some cases, healthcare worker addiction can lead them to use prescription drugs intended for patients or steal them to be sold for personal benefit.A recent survey sponsored by Invistics, acquired by Wolters Kluwer Health earlier this year, found that despite 98% of healthcare executives agreeing that drug diversion occurs in hospitals, nearly four in
Read More
Integral Secures $6.9M to Expand Real-Time Compliance for Life Sciences
What You Should Know:
- Integral, an innovator in safeguarding privacy and maximizing data quality raises $6.9M in seed funding to protect sensitive health data and provide automated expert certification software that enables health and life sciences companies access to compliant, rich, de-identified data in hours, rather than months.
- The seed round was led by Haystack, The General Partnership, and Virtue Ventures, with additional support from Also Capital, Array Ventures,
Read More
